Quest Diagnostics Inc vs iShares Bitcoin Trust — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while iShares Bitcoin Trust trades at $36.26. The key difference: Quest Diagnostics Inc pays a 1.45% dividend while iShares Bitcoin Trust pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| DGX | IBIT | |
|---|---|---|
Market Cap | $26.21B | — |
Sector | Health | Crypto-linked |
52-Week High | $238.50 | $71.29 |
52-Week Low | $173.49 | $33.29 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →